"St. Luke's Hospital - Warren Campus has invested $90-million in patient friendly upgrades at its main campus and satellite locations throughout the area. Our goal is twofold: to provide our patients with excellent medical care in comfortable surroundings and to provide easy access to our services where our patients live and work."

During the past decade, Warren Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 11 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Warren Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 9 trials, followed by "NSABP Foundation Inc" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Tragara Pharmaceuticals, Inc." with 2 trials sponsored and "Frederick Schmitt" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Warren Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Warren Hospital" are "Breast Cancer" (5 trials), "Endometrial Clear Cell Adenocarcinoma" (3 trials), "Endometrial Serous Adenocarcinoma" (3 trials), "Endometrial Adenocarcinoma" (2 trials) and "Endometrial Adenosquamous Carcinoma" (2 trials). Many other conditions were trialed in "Warren Hospital" in a lesser frequency.

Most popular intervention types in "Warren Hospital" are "Drug" (17 trials), "Biological" (7 trials), "Other" (7 trials), "Radiation" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Bevacizumab" (5 trials), "Carboplatin" (4 trials), "Paclitaxel" (4 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Warren Hospital" are 11 trials for "Female" genders, 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Warren Hospital". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Warren Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Warren Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".